News

Under the terms of the licensing agreement, Gastrotech will receive a global exclusive license to develop and market GTP-010 for irritable bowel syndrome (IBS) and functional dyspepsia. Lilly

The company previously has acquired all of the issued and outstanding capital stock of Raygere Limited, a company organized under the laws of the British Virgin Islands and

The approval is based on results from the Acuity trial of 13,819 patients with acute coronary syndromes (ACS). Acuity has demonstrated that Angiox with or without a glycoprotein

In addition, Medtronic has acquired a minority stake in Arbor. Arbor retains its exclusive rights to the modular Trilogy Aortic Valve System and sutureless TRE implantation technologies. The

In addition, the CHMP has also adopted a positive opinion, in coordination with the World Health Organization (WHO), for Aluvia (lopinavir/ritonavir), the tradename of the same lower-strength tablet

Elesclomol (formerly STA-4783) is being developed under a global collaboration agreement between Synta and GlaxoSmithKline (GSK). Orphan drug status is designed to encourage biotechnology and pharmaceutical companies to

BioSphere expects to commence shipments of Embosphere Microspheres to China in the first quarter of 2008. Richard Faleschini, president and CEO of BioSphere, said: “We believe that among

Under the terms of the agreements, Arno has acquired the rights to several small molecules for the treatment of cancer, including OSU-03012 (NSC D728209) and OSU-HDAC42 (NSC D736012).

David Tsur, CEO of Kamada, said: “Hercules’s debt financing will help fund a mixture of Kamada’s clinical programs and strategic priorities that enable our continued development and marketing